15 Infections Infections occurred in 68% (41/ 60) of children receiving 3 mg/ kg over 52 weeks, 65% (37/ 57) of children receiving infliximab 6 mg/ kg over 38 weeks and 47% (28/ 60) of children receiving placebo over 14 weeks.